Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Precision Medicine Market Heading Into 2029?

The market for precision medicine has experienced significant growth recently, surging from a value of $80.15 billion in 2024 to an estimated $87.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.7%. Factors such as rising incidence of cancer, a growing incidence of mental health disorders, an escalation in respiratory diseases, enhanced funding, an expanding elderly population, an increase in pharmaceutical research and development spending, and an upsurge in healthcare expenditure have all contributed to the robust growth in the historic period.

The market size of precision medicine is projected to experience robust growth in the forthcoming years. It is expected to reach “$126.14 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%.” Factors contributing to this growth during the predicted period include a rising elderly population, an increase in the prevalence of cancer, the promising potential of emerging markets, the advent of new pathogen infections, elevated spending on research and development, and an increase in healthcare expenditure. Key trends for the forecast period comprise the adoption of artificial intelligence technologies for enhanced competitiveness, providing diagnosis and personalized treatment for immune-related diseases, the investment in expanded research and development activities, and forming alliances with technology and healthcare entities to bolster their product range.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

Which Factors Are Pushing The Precision Medicine Market Forward?

The increase in cancer incidences worldwide is anticipated to spur the expansion of the precision medicine market. Cancer, being a major worldwide mortality cause, affects one in every five individuals at a certain point in their life. Analyzing DNA from cancerous tumors to identify mutations or any genetic abnormalities leading to cancer is what precision medicine in cancer involves. This allows doctors to pinpoint a treatment that accurately addresses the DNA alterations in a specific patient’s cancer. The World Health Organization, a Switzerland-based authority responsible for global public health, indicated in February 2024 that by 2050, the number of new cancer cases is set to exceed 35 million, showing a 77% rise from the estimated 20 million cases in 2022. Consequently, the increasing cancer incidence propels the expansion of the precision medicine market.

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

Which Trends Are Redefining The Future Landscape Of The Precision Medicine Industry?

An increasing trend of collaborations and acquisitions amongst precision medicine organizations is broadening their oncological and non-oncological methodologies. Ongoing research and development in fresh areas within precision medicine is boosted by these affiliations, serving to amplify the abilities and methods of the companies involved. For instance, UK pharmaceutical firm GSK plc, in September 2022, amplified its collaboration with Tempus, a precision medicine company from the US. This alliance, planned for three years, intends to refine clinical trial design, expedite patient inclusion, and pinpoint drug targets using Tempus’ AI-facilitated platform and vast patient data that’s been de-identified. This collaboration, building on their past work, is anticipated to augment GSK’s R&D abilities, chiefly in oncology.

Which Organizations Are Driving Progress In The Precision Medicine Industry?

Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Precision Medicine Industry?

North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model